Data-Backed Trial Design– Applying AI to Clinical Outcome Analysis
Global spending on clinical trials is expected to reach $68.9 billion per year by 2025…
Certara2023年3月17日
Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara
Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…
Certara2023年3月10日
What you should know about FDA Project Optimus for your oncology drug approval
歴史的に、がん治療薬の投与戦略は最大耐容量に焦点が当てられてきました。This…
Certara2023年3月10日
RAPS Sponsored Webcast: Oops, I messed Up! How to Avoid (and Fix) Common Regulatory Submission Mistakes
うっかりミス、誰にでも起こり得ます。Everyone has made or seen one, and sometimes it is…
Certara2023年3月9日
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel…
Certara2023年3月7日
GlobalSubmit™ eCTD Platform
GlobalSubmit enables teams to simplify the eCTD submission process to successfully publish, validate, and review…
Certara2023年3月3日
Drug Development Considerations for Live Biotherapeutic Products
A new class of complex biologics has emerged in recent years. These are classified in…
Certara2023年3月3日
